278
Views
11
CrossRef citations to date
0
Altmetric
Rapid Communication

UVA radiation augments cytotoxic activity of psoralens in melanoma cells

, , , , , , , & show all
Pages 734-739 | Received 06 Nov 2016, Accepted 12 Feb 2017, Published online: 13 Mar 2017

References

  • Beberok A, Buszman E, Wrześniok D, Otręba M, Trzcionka J. 2011. Interaction between ciprofloxacin and melanin: the effect on proliferation and melanization in melanocytes. Eur J Pharmacol. 669:32–37.
  • Bethea D, Fullmer B, Syed S, Seltzer G, Tiano J, Rischko C, Gillespie L, Brown D, Gasparro FP. 1999. Psoralen photobiology and photochemotherapy: 50 years of science and medicine. J Dermatol Sci. 19:78–88.
  • Carneiro Leite V, Ferreira Santos R, Chen Chen L, Andreu Guillo L. 2004. Psoralen derivatives and longwave ultraviolet irradiation are active in vitro against human melanoma cell line. J Photochem Photobiol B. Biol. 76:49–53.
  • Dellinger RW, Liu-Smith F, Meyskens FL. Jr. 2014. Continuing to illuminate the mechanisms underlying UV-mediated melanomagenesis. J Photochem Photobiol B, Biol. 138:317–323.
  • Garbe C, Eigentler T, Keilholz U, Hauschild A, Kirkwood JM. 2011. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 16:5–24.
  • Ghiorzo P, Pastorino L, Pizzichetta MA, Bono R, Queirolo P, Talamini R, Annessi G, Bruno W, Nasti S, Gargiulo S, et al. 2009. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma. Melanoma Res. 19:142–145.
  • Halpern SM, Anstey AV, Dawe RS, Diffey BL, Farr PM, Ferguson J, Hawk JL, Ibbotson S, McGregor JM, Murphy GM, et al. 2000. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group. Br J Dermatol. 142:22–31.
  • Isoldi MC, Scarparo AC, Schumacher RI, Castrucci AM. 1999. Psoralen activity and binding sites in melanotic and amelanotic human melanoma cells. Pigment Cell Res. 12:367–375.
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. 2011. Global cancer statistics. CA Cancer J Clin. 61:69–90.
  • Keane TE, Petros JA, Velimirovich B, Yue KT, Graham SD Jr. 1994. Methoxypsoralen phototherapy of transitional cell carcinoma. Urology. 44:842–846.
  • Meredith P, Sarna T. 2006. The physical and chemical properties of eumelanin. Pigment Cell Res. 19:572–594.
  • Oliveira AM, Raposo MM, Oliveira-Campos AM, Machado AE, Puapairoj P, Pedro M, Nascimento MS, Portela C, Afonso C, Pinto M. 2006. Psoralen analogues: synthesis, inhibitory activity of growth of human tumor cell lines and computational studies. Eur J Med Chem. 41:367–372.
  • Panno ML, Giordano F. 2014. Effects of psoralens as anti-tumoral agents in breast cancer cells. World J Clin Oncol. 5:348–358.
  • Premi S, Brash DE. 2015. Unanticipated role of melanin in causing carcinogenic cyclobutane pyrimidine dimmers. Mol Cell Oncol. 3:e1033588.
  • Premi S, Wallisch S, Mano CM, Weiner AB, Bacchiocchi A, Wakamatsu K, Bechara EJ, Halaban R, Douki T, Brash DE. 2015. Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science. 347:842–847.
  • Rather MA, Bhat BA, Qurishi MA. 2013. Multicomponent phytotherapeutic approach gaining momentum: is the “one drug to fit all” model breaking down? Phytomedicine. 21:1–14.
  • Sandru A, Voinea S, Panaitescu E, Blidaru A. 2014. Survival rates of patients with metastatic malignant melanoma. J Med Life. 7:572–576.
  • Surażyński A, Pałka J, Wrześniok D, Buszman E, Kaczmarczyk P. 2001. Melanin potentiates daunorubicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur J Pharmacol. 419:139–145.
  • Wrześniok D, Buszman E, Miernik-Biela E. 2012. Amikacin, kanamycin and tobramycin binding to melanin in the presence of Ca2+ and Mg2+ ions. Acta Pol Pharm. 69:1035–1041.
  • Wu JZ, Situ ZQ, Wang W, Chen JY, Liu B. 1992. Antitumor activity of psoralen on mucoepidermoid carcinoma cell line MEC-1. Chin Med J. 105:913–917.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.